IJGC conversations cover art

All Episodes

IJGC conversations — 87 episodes

#
Title
1

KEYNOTE-B96: Pembrolizumab and Weekly Paclitaxel in Ovarian Cancer

2

FIGO/IGCS Statement on Topical Treatments for HPV CIN3+

3

Revisited: Neoadjuvant Chemotherapy: Mortality in Low- vs High-Volume Centers

4

GLP1-RAs and Cancer Risk in Non-diabetic Patients

5

Statin Use in Gynecologic Cancer Therapy

6

Empty Lymph Node Packet in SLN Mapping for Endometrial Cancer

7

Contralateral pelvic lymph node metastases in patients with unilateral early-stage epithelial ovarian cancer

8

Salpingo-oophorectomy at Radical Hysterectomy for Cervical Adenocarcinoma

9

Lymphadenectomy in Early-Stage Ovarian Cancer

10

Vaccine Therapy in Ovarian Cancer: Role of Gemogenovatucel-T

11

Ribociclib Plus Letrozole in Recurrent Low-Grade Serous Carcinoma of the Ovary: GOG 3026

12

Single-Port Robotic Surgery: Safety and Feasibility

13

GLP1-Receptor Agonists in Endometrial Cancer

14

Mentor's Podcast: Mario M. Leitao, Jr.

15

Topical Treatments for HPV: Fact or Flawed Science

16

Molecular Profile-Based Adjuvant Treatment Endometrial Cancer: PORTEC-4a

17

Pembrolizumab and weekly paclitaxel for platinum-resistant ovarian cancer

18

Risk-reducing Salpingectomy with Delayed Oophorectomy

19

De-escalation in Gynecologic Oncology

20

Mentor's Podcast: Reitan Ribeiro

21

Uterine Leiomyosarcoma

22

Neoadjuvant Chemotherapy: Mortality in Low- vs High-Volume Centers

23

Mirvetuximab in Low-Grade Ovarian Cancer with Alessandro D. Santin

24

ICG Angiography for Bowel Anastomosis Evaluation with Stephanie Gill

25

ESMO 2025 Highlights: Top Studies In Gynecologic Oncology with Mariana Scaranti

26

ESGO-ESTRO-ESP 2025 Endometrial Cancer Guidelines with Nicole Concin

27

ctDNA & diagnosis of ovarian cancer with Cristina Taliento and Giuseppe Vizzielli

28

IJGC conversations 2025 December Editor's Choice

29

Revisited: ctDNA: Results from CALLA Trial with Bradley Monk

30

Revisited: RAMP 201 Results: Avutometinib and Defactinib in Low-Grade Serous Ovarian Cancer with Susana N Banerjee and Rachel N. Grisham

31

Revisited: SENTIX Trial with David Cibula

32

Revisited: ESGO/INCIP 2025 Guidelines for Cancer in Pregnancy with Frédéric Amant

33

SUROVA Study: Surgery vs Neoadjuvant Therapy in Ovarian Cancer with Luis Chiva

34

Updates in Radiotherapy in Gynecologic Cancers with Junzo Chino

35

IJGC conversations 2025 November Editor's Choice

36

Results of the MoST-CIRCUIT Trial with Oliver Klein

37

Addition of Metronidazole to Prevent SSI with Megan Gorman and Marina Frimer

38

Checkpoint Inhibitor Rechallenge in Endometrial Cancer with Brian Slomovitz

39

PEACOCC Trial: Pembrolizumab in Clear Cell Cancer with Rebecca Kristeleit

40

ADCs and Oral Mucositis with Michelle D.S. Lightfoot

41

IJGC conversations 2025 October Editor's Choice

42

ROSELLA Trial: Relacorilant in Platinum-resistant Ovarian Cancer with Alexander B. Olawaiye

43

Carcinosarcoma with no myoinvasion with Giuseppe Cucinella and Mario M. Leitao, Jr.

44

IJGC conversations 2025 September Editor's Choice

45

SENTIX Trial with David Cibula

46

RAMP 201 Results: Avutometinib and Defactinib in Low-Grade Serous Ovarian Cancer with Susana N Banerjee and Rachel N. Grisham

47

Surgical Approach in Recurrent Granulosa Cell Tumor with Tyler Hillman and Allison Lynn Brodsky

48

ctDNA: Results from CALLA Trial with Bradley Monk

49

ESGO/INCIP 2025 Guidelines for Cancer in Pregnancy with Frédéric Amant

50

IJGC conversations 2025 August Editor's Choice

51

IJGC EiC Summer Podcasts: HIPEC in Platinum-Sensitive Ovarian Cancer (HORSE Trial) with Anna Fagotti

52

IJGC EiC Summer Podcasts: ctDNA in Endometrial Cancer with Ilaria Capasso, Camilla Nero, and Evelyn A. Reynolds

53

IJGC EiC Summer Podcasts: MIS in Simple Hysterectomy: SHAPE Subanaylsis with Marie Plante

54

Impact of Surgical Timing and Residual Disease in Ovarian Cancer with Martina Angeles and Alejandra Martinez

55

Impact of RCTs on Clinical Practice with Floriane Jochum

56

Lymphadenectomy in Low-Grade Ovarian Cancer with Elizabeth Tubridy and Dimitrios Nasioudis

57

IJGC conversations 2025 July Editor's Choice

58

ctDNA in Ovarian Cancer with Henri Azaïs

59

2025 GTD Guidelines with Christianne Lok and Michael Seckl

60

Peritoneal Cytology in Endometrial Cancer with Diletta Fumagalli and Gretchen E. Glaser

61

Radiation alone vs Chemoradiation in Intermediate Risk Cervical Cancer with Drs. Agustí and Viveros-Carreño

62

IJGC conversations 2025 June Editor's Choice

63

ctDNA in Endometrial Cancer with Ilaria Capasso, Camilla Nero, and Evelyn A. Reynolds.

64

IDEAL Framework: Robotics Innovation and Evaluation with Hani Marcus

65

Modified Radical Hysterectomy for Stage IB1 Cervical Cancer with Koji Matsuo

66

Risk Factor for Unsuccessful SLN Mapping with Félix Boria

67

IJGC conversations 2025 May Editor's Choice

68

SUGAR Initiative: Glycemic control in the perioperative period with Jolyn Taylor

69

HIPEC in Platinum-Sensitive Ovarian Cancer (HORSE Trial) with Anna Fagotti

70

Molecular Targets in Endometrial Cancer: Real World Outcomes (ECMT2) with Angeles Alvarez Secord

71

IJGC conversations 2025 April Editor's Choice

72

Real-word PARPi Maintenance and Recurrence Patterns with Anna Fagotti and Matteo Loverro

73

Substantial LVSI and Recurrence in Endometrial Cancer with Nadeem Abu-Rustum and Christian Dagher

74

Surgery for Stage IV Ovarian Cancer with Floriane Jochum

75

Rare gynecologic cancers with IJGC fellows

76

QoL Assessment on SHAPE Trial with Sarah E. Ferguson

77

De-escalation in Gynecologic Oncology with Núria Agustí

78

IJGC conversations 2025 February Editor's Choice

79

LANCE Trial: Results of Feasibility Phase with Jose Alejandro Rauh-Hain

80

Ovarian cancer risk among older patients with stable adnexal masses with Elizabeth (Betty) Suh-Burgmann

81

Preoperative Tumor Size and Final Pathology in Cervical Cancer with Teresa Pan

82

Oral Contraceptive Impact on p53 Signatures with Ramlogan Sowamber

83

PRIMA Trial: Overall Survival Results with Antonio González-Martín

84

GOG3053/ENGOT EN11/KEYNOTE B21:dMMR Outcomes with Brian Slomovitz

85

Recent Trends in Radical Hysterectomy Approach after LACC Trial with Gabriel Levin

86

MIS in Simple Hysterectomy: SHAPE Subanaylsis with Marie Plante

87

Secondary Cytoreductive Surgery in Endometrial Cancer with Francesco Fanfani